СT and MRI in the assessment of resectable and borderline resectable pancreatic tumors

Aim. To evaluate the capabilities of CT and MRI in the assessment of resectable and potentially resectable pancreatic tumors.

Materials and methods. From 2015 to 2020 CT and MRI examination of the abdomen was performed in 220 patients with pancreatic ductal adenocarcinoma. The average age of the patients was 54.6 ± 9.9 years. 198 (90%) patients had a tumor of the pancreas head, 22 (10%) patients had a tumor of the body or tail of the organ. 110 (50%) people were recognized as inoperable. The results of examination of 88 (40%) patients were subjected to in-depth analysis.

Results. Eighty eight patients were assessed for tumor resectability. In 36 (40.9%) cases, the neoplasm was recognized as resectable, and the standard resection was performed. In 52 (59.1%) cases, the tumor was determined as borderline resectable; extended gastropancreatoduodenal resection was performed.The usefulness of CT was shown in assessing the features of the variable vascular anatomy of the hepatopancreatobiliary area, determining the nature of the involvement of key vessels in the pathological process and lesions of the pancreas as a whole. The importance of using multiphase CT scanning is demonstrated and emphasized. The advantages of the MRI are indicated, including examples of the effective use of diffusion-weighted images.

Conclusion. Multiphase MDCT and MRI with dynamic contrast enhancement are the leading methods of radiological diagnosis of malignant tumors of the pancreas and effectively complement each other.

1. Zlokachestvennye novoobrazovaniya v Rossii v 2018 godu (zabolevaemost' i smertnost') [Malignant tumors in Russiain 2018 (morbidity and mortality)]. Ed. by Kaprin A.D., Starinskiy V.V., Petrova G.V. M.: MNIOI im. P.A. Gertsena – filial FGBU ”NMITS radiologii” Minzdrava Rossii, 2019. 250 p. (In Russian)

2. Karmazanovsky G.G. Solid pancreatic tumors: protocols of radiological examinations and differential diagnosis (lecture, part 1). Medical Visualization. 2016; 4: 54–63. (In Russian)

3. Kim H.J., Park M.S., Lee J.Y., Han K., Chung Y.E., Choi J.Y., Kim M.J., Kang C.M. Incremental role of pancreatic magnetic resonance imaging after staging computed tomography to evaluate patients with pancreatic ductal adenocarcinoma. Cancer Res. Treat. 2019; 51 (1): 24–33. http://doi.org/10.4143/crt.2017.404

4. Gillen S., Schuster T., Meyer Zum Büschenfelde C., Friess H., Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010; 7 (4): e1000267. http://doi.org/10.1371/journal.pmed.1000267

5. Kriger A.G., Karmazanovsky G.G., Smirnov A.V., Kharazov A.F., Gorin D.S., Raevskaya M.B., Galkin G.V., Revishvili A.Sh. Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion. Pirogov Russian Journal of Surgery = Khirurgiya. Zhurnal imeni N.I. Pirogova. 2018; 12: 21–29. http://doi.org/10.17116/hirurgia201812121 (In Russian)

6. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014; 64 (1): 9–29. http://doi.org/10.3322/caac.21208

7. Kamisawa T., Wood L.D., Itoi T., Takaori K. Pancreatic cancer. Lancet. 2016; 388 (10039): 73–85. http://doi.org/10.1016/S0140-6736(16)00141-0

8. Patyutko Yu.I., Kudashkin N.E., Kotel’nikov A.G., Chistyakova O.V. Total pancreatectomy for pancreatic cancer. Pirogov Russian Journal of Surgery /Khirurgiya. Zhurnal imeni N.I. Pirogova. 2016; 9: 13–20. (In Russian)

9. Revishvili A.Sh., Kriger A.G., Vishnevskii V.A., Smirnov A.V., Berelavichus S.V., Gorin D.S., Akhtanin E.A., Kaldarov A.R., Raevskaya M.B., Zakharova M.A. Current issues in pancreatic surgery. Pirogov Russian Journal of Surgery /Khirurgiya. Zhurnal imeni N.I. Pirogova. 2018; 9: 5–14. http://doi.org/10.17116/hirurgia20180915 (In Russian)

10. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2015 godu [The state of cancer care for the population of Russia in 2015]. Ed. by Kaprin A.D., Starinskii V.V., Petrova G.V. Moscow: RIIS FIAN; 2016. 236 p. (In Russian)

11. Beltrame V., Gruppo M., Pedrazzoli S., Merigliano S., Pastorelli D., Sperti C. Mesenteric-portal vein resection during pancreatectomy for pancreatic cancer. Gastroenterol. Res. Pract. 2015; 2015: 659730. http://doi.org/10.1155/2015/659730

12. Bockhorn M., Uzunoglu F.G., Adham M., Imrie C., Milicevic M., Sandberg A.A., Asbun H.J., Bassi C., Büchler M., Charnley R.M., Conlon K., Cruz L.F., Dervenis C., Fingerhutt A., Friess H., Gouma D.J., Hartwig W., Lillemoe K.D., Montorsi M., Neoptolemos J.P., Shrikhande S.V., Takaori K., Traverso W., Vashist Y.K., Vollmer C., Yeo C.J., Izbicki J.R. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014; 155 (6): 977–988. http://doi.org/10.1016/j.surg.2014.02.001

13. Zhou Y., Zhang Z., Liu Y., Li B., Xu D. Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J. Surg. 2012; 36 (4): 884–891. http://doi.org/10.1007/s00268-012-1461-z

14. Karmazanovsky G.G., Nerestyuk Ya.I., Kriger A.G., Khairieva A.V. Diagnostic value of three-dimensional reconstructions of CT images in patients with ductal pancreas adenocarcinoma. Russian Electronic Journal of Radiology (REJR). 2017; 7 (1): 69–76. http://doi.org/10.21569/2222-7415-2017-7-1-69-76 (In Russian)

15. Karmazanovsky G.G. Differential diagnosis and analysis of pancreatic cancer resectability using CT and MRI. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2019; 24 (3): 22–35. https://doi.org/10.16931/1995-5464.2019322-35 (In Russian)

16. Lee E.S., Lee J.M. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J. Gastroenterol. 2014; 20 (24): 7864–7877. http://doi.org/10.3748/wjg.v20.i24.7864

17. Tamburrino D., Riviere D., Yaghoobi M., Davidson B.R., Gurusamy K.S. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst. Rev. 2016; 9 (9): CD011515. http://doi.org/10.1002/14651858

18. Raman S.P., Horton K.M., Fishman E.K. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography. Cancer J. 2012; 18 (6): 511–522. http://doi.org/10.1097/PPO.0b013e318274a461

19. Ishigami K., Yoshimitsu K., Irie H., Tajima T., Asayama Y., Nishie A., Hirakawa M., Ushijima Y., Okamoto D., Nagata S., Nishihara Y., Yamaguchi K., Taketomi A., Honda H. Diagnostic value of the delayed phase image for iso-attenuating pancreatic carcinomasinthepancreaticparenchymalphaseonmultidetector computed tomography. Eur. J. Radiol. 2009; 69 (1): 139–146. https://doi.org/10.1016/j.ejrad.2007.09.012

20. Agarwal B., Abu-Hamda E., Molke K.L., Correa A.M., Ho L. Endoscopic ultrasound-guided fine needle aspiration andmultidetector spiral CT in the diagnosis of pancreatic cancer. Am. J. Gastroenterol. 2004; 99 (5): 844–850. http://doi.org/10.1111/j.1572-0241.2004.04177.x

21. Bronstein Y.L., Loyer E.M., Kaur H., Choi H., David C., DuBrow R.A., Broemeling L.D., Cleary K.R., Charnsangavej C. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am. J. Roentgenol. 2004; 182 (3): 619–623. http://doi.org/10.2214/ajr.182.3.1820619

22. Tamm E.P., Loyer E.M., Faria S.C., Evans D.B., Wolff R.A., Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom. Imaging. 2007; 32 (5): 660–667. http://doi.org/10.1007/s00261-007-9298-x

23. Chen F.M., Ni J.M., Zhang Z.Y., Zhang L., Li B., Jiang C.J. Presurgical evaluation of pancreatic cancer: a comprehensive imaging comparison of CT versus MRI. AJR Am. J. Roentgenol. 2016; 206 (3): 526–535. http://doi.org/10.2214/AJR.15.15236

24. Sotnikov A.S. Morfofunktsional'noe obosnovanie rasshirennoi gastropankreatoduodenal'noi rezektsii s korrektsiei portal'nogo krovotoka [Morphological and functional justification of extended gastropancreatoduodenectomy with correction of portal blood flow: author's abstract of dis….. doct. med. sci.]. Saint-Petersburg, 2012. 41 p. (In Russian)

25. Manak E., Merkel S., Klein P., Papadopoulos T., Bautz W.A., Baum U. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations. Abdom. Imaging. 2009; 34 (1): 75–80. http://doi.org/10.1007/s00261-007-9285-2

26. Gilbert J.W., Wolpin B., Clancy T., Wang J., Mamon H., Shinagare A.B., Jagannathan J., Rosenthal M. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Ann. Oncol. 2017; 28 (9): 2067–2076. Published online 2017 Apr. 12. http://doi.org/10.1093/annonc/mdx180

27. Nikulin M.P., Sel'chuk V.Yu., Chistyakov S.S., Ibragimov T.F., Titova G.V. Pancreas cancer. Russian Medical Journal. 2006; 14 (24): 1726–1736. (In Russian)

28. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015; 136 (5): E359–386. http://doi.org/10.1002/ijc.29210